Annual CFO
-$180.15 M
+$139.01 M+43.56%
31 December 2023
Summary:
GeneDx Holdings annual cash flow from operations is currently -$180.15 million, with the most recent change of +$139.01 million (+43.56%) on 31 December 2023. During the last 3 years, it has fallen by -$87.02 million (-93.44%). WGS annual CFO is now -861.91% below its all-time high of -$18.73 million, reached on 01 December 2019.WGS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$4.39 M
+$110.00 K+2.44%
30 September 2024
Summary:
GeneDx Holdings quarterly cash flow from operations is currently -$4.39 million, with the most recent change of +$110.00 thousand (+2.44%) on 30 September 2024. Over the past year, it has increased by +$36.83 million (+89.34%). WGS quarterly CFO is now at all-time high.WGS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$55.17 M
+$36.83 M+40.03%
30 September 2024
Summary:
GeneDx Holdings TTM cash flow from operations is currently -$55.17 million, with the most recent change of +$36.83 million (+40.03%) on 30 September 2024. Over the past year, it has increased by +$159.77 million (+74.33%). WGS TTM CFO is now -30.71% below its all-time high of -$42.21 million, reached on 01 March 2021.WGS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WGS Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.6% | +89.3% | +74.3% |
| 3 y3 years | -93.4% | +93.8% | +60.1% |
| 5 y5 years | - | - | - |
WGS Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -93.4% | +43.6% | at high | +95.0% | at high | +82.7% |
| 5 y | 5 years | -861.9% | +43.6% | at high | +95.0% | -30.7% | +82.7% |
| alltime | all time | -861.9% | +43.6% | at high | +95.0% | -30.7% | +82.7% |
GeneDx Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.39 M(-2.4%) | -$55.17 M(-40.0%) |
| June 2024 | - | -$4.50 M(-72.6%) | -$92.00 M(-34.7%) |
| Mar 2024 | - | -$16.41 M(-45.0%) | -$141.00 M(-21.7%) |
| Dec 2023 | -$180.15 M(-43.6%) | -$29.86 M(-27.6%) | -$180.15 M(-16.2%) |
| Sept 2023 | - | -$41.23 M(-22.9%) | -$214.94 M(-18.0%) |
| June 2023 | - | -$53.50 M(-3.7%) | -$262.08 M(-10.6%) |
| Mar 2023 | - | -$55.56 M(-14.1%) | -$293.22 M(-8.1%) |
| Dec 2022 | -$319.15 M | -$64.65 M(-26.8%) | -$319.15 M(+4.1%) |
| Sept 2022 | - | -$88.36 M(+4.4%) | -$306.49 M(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$84.64 M(+3.9%) | -$289.06 M(+25.8%) |
| Mar 2022 | - | -$81.49 M(+56.8%) | -$229.72 M(+20.6%) |
| Dec 2021 | -$190.43 M(+104.5%) | - | - |
| Dec 2021 | - | -$51.98 M(-26.7%) | -$190.43 M(+37.5%) |
| Sept 2021 | - | -$70.94 M(+180.4%) | -$138.45 M(+105.1%) |
| June 2021 | - | -$25.30 M(-40.1%) | -$67.51 M(+59.9%) |
| Mar 2021 | - | -$42.21 M | -$42.21 M |
| Dec 2020 | -$93.13 M(+397.3%) | - | - |
| Dec 2019 | -$18.73 M | - | - |
FAQ
- What is GeneDx Holdings annual cash flow from operations?
- What is the all time high annual CFO for GeneDx Holdings?
- What is GeneDx Holdings annual CFO year-on-year change?
- What is GeneDx Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for GeneDx Holdings?
- What is GeneDx Holdings quarterly CFO year-on-year change?
- What is GeneDx Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for GeneDx Holdings?
- What is GeneDx Holdings TTM CFO year-on-year change?
What is GeneDx Holdings annual cash flow from operations?
The current annual CFO of WGS is -$180.15 M
What is the all time high annual CFO for GeneDx Holdings?
GeneDx Holdings all-time high annual cash flow from operations is -$18.73 M
What is GeneDx Holdings annual CFO year-on-year change?
Over the past year, WGS annual cash flow from operations has changed by +$139.01 M (+43.56%)
What is GeneDx Holdings quarterly cash flow from operations?
The current quarterly CFO of WGS is -$4.39 M
What is the all time high quarterly CFO for GeneDx Holdings?
GeneDx Holdings all-time high quarterly cash flow from operations is -$4.39 M
What is GeneDx Holdings quarterly CFO year-on-year change?
Over the past year, WGS quarterly cash flow from operations has changed by +$36.83 M (+89.34%)
What is GeneDx Holdings TTM cash flow from operations?
The current TTM CFO of WGS is -$55.17 M
What is the all time high TTM CFO for GeneDx Holdings?
GeneDx Holdings all-time high TTM cash flow from operations is -$42.21 M
What is GeneDx Holdings TTM CFO year-on-year change?
Over the past year, WGS TTM cash flow from operations has changed by +$159.77 M (+74.33%)